Tatsuya Shimomura

10PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSurgeryPharmacogenomicsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 15, 2026
Survival Benefit of ARSI Therapy in Japanese mCSPC: A Systematic Review and Meta-Analysis.

|Aug 08, 2026
Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer.

|Apr 17, 2026
Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features.

|Aug 20, 2025
Editorial Comment to "Preliminary Report on the Efficacy and Safety of Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer: YUSHIMA Study".

Tatsuya Shimomura

|Aug 07, 2025
Bilateral vas deferens suturing to prevent inguinal hernias after radical prostatectomy.

Kenichi Hata, Yuma Goto, Masaki Hashimoto

|Apr 09, 2025
Evaluating CRPC Definition: Comparing Upfront ARSI and Conventional Hormonal Therapy for Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Real World Propensity Score Matched Cohort.

Tatsuya Shimomura, Fumihiko Urabe, Katsuki Muramoto

Pageof 2

Frequent Collaborators

6 joint publications

Shunsuke Tsuzuki

6 joint publications

Fumihiko Urabe

5 joint publications

Takafumi Yanagisawa

4 joint publications

Jun Miki